Skip to content
drillr.ai
Sign up

ALEC

Alector, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.46
−1.99%
Ask drillr

  • Aug 7, 2026, 00:12 UTC

    Alector reported a second-quarter loss of $0.21 per share, beating the Zacks Consensus Estimate of a loss of $0.24 and improving from a loss of $0.30 per share a year earlier.

    Source:

  • Jul 8, 2026, 21:20 UTC

    GSK terminated its neuroscience collaboration agreement with Alector covering two experimental antibody drugs after both drug candidates suffered clinical setbacks.

    Source: